Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia

Raffard, S.; Norton, J.; Van der Linden, Martial; Lançon, C.; Benoit, M.; Capdevielle, D.

doi:10.1016/j.jpsychires.2022.01.033

Article (Scientific journals)

Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia

Raffard, S.; Norton, J.; Van der Linden, Martial et al.

2022 • In Journal of Psychiatric Research, 147 (March), p. 274-282

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/267706

DOI
10.1016/j.jpsychires.2022.01.033

PubMed
35074744

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S0022395622000334-main.pdf

Publisher postprint (649.01 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Avolition; Longitudinal study; Negative symptoms; Self-assessment

Abstract :

[en] Aims: Avolition defined as a lack of interest or engagement in goal-directed behavior plays a key role in everyday functioning in schizophrenia and is considered as one of the main contributors to the burden of disease. The aim of this study was to 1) validate the self-report BIRT Motivation Questionnaire (BMQ-S) seldom used before in schizophrenia 2) examine the degree of agreement between the BMQ-S and its informant-report version 3) to assess its ability to predict real-world outcome at 12 month follow-up. Methods: One hundred and twenty-two (51.9% inpatients) adults with a diagnosis of schizophrenia were included. Exploratory Factor analysis was performed on the BMQ-S to identify the underlying structure. Real life functioning was measured with the Global Assessment of Functioning scale (GAF). Convergent validity was assessed with the Scale for Assessment of Negative Symptom (SANS) and the Lille Apathy Rating Scale (LARS). Results: The main psychometric properties of the BMQ-S (internal consistency, test-retest reliability) were satisfactory. Exploratory factorial analysis revealed a 4-factor model which explained 76% of the overall variance. The BMQ-S correlated significantly with the LARS and the SANS avolition subscore suggesting adequate convergent validity. The correlation between the BMQ-S and the clinician-report version was 0.48. The global score and in particular the Initiation/disorganisation dimension was a significant predictor of global functioning at 12-months even when adjusted for age, chlorpromazine intake and depression. Conclusion: Our findings indicate that the BMQ-S has satisfactory psychometric properties and that schizophrenia patients can reliably assess their lack of motivation. Self-evaluation of avolition should be considered in the overall prediction of real-world functioning in schizophrenia. © 2022 Elsevier Ltd

Disciplines :

Neurosciences & behavior

Author, co-author :

Raffard, S.; University Department of Adult Psychiatry, Hôpital de la Colombière, CHU Montpellier, Montpellier, France, Univ Paul Valéry Montpellier 3, Univ. Montpellier, EPSYLON EA, Montpellier, France

Norton, J.; INSERM U1298, Montpellier, France, University of Montpellier, Montpellier, France

Van der Linden, Martial ; Université de Liège - ULg

Lançon, C.; Aix-Marseille Univ., Chronic Diseases and Quality of Life - Research Unit, EA 3279 - Public Health, Marseille, 13005, France

Benoit, M.; Psychiatry - Clinical Neuroscience Department, Pasteur Hospital, University of Nice Sophia-Antipolis, Nice, France

Capdevielle, D.; University Department of Adult Psychiatry, Hôpital de la Colombière, CHU Montpellier, Montpellier, France, INSERM U1298, Montpellier, France, University of Montpellier, Montpellier, France

Language :

English

Title :

Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia

Publication date :

2022

Journal title :

Journal of Psychiatric Research

ISSN :

0022-3956

eISSN :

1879-1379

Publisher :

Elsevier, United Kingdom

Volume :

147

Issue :

March

Pages :

274-282

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 01 February 2022

Statistics

Number of views

80 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Addington, et al. Psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia research, 1996, 10.1016/0920-9964(95)00070-4 Submitted for publication.
Allen, M.J., Yen, W.M., Introduction to Measurement Theory. 1979, Brooks/Cole, Monterey (CA).
Allott, K., van-der-El, K., Bryce, S., Parrish, E.M., McGurk, S.R., Hetrick, S., Bowie, C.R., Kidd, S., Hamilton, M., Killackey, E., Velligan, D., Compensatory interventions for cognitive impairments in psychosis: a systematic review and meta-analysis. Schizophr. Bull. 46:4 (2020), 869–883, 10.1093/schbul/sbz134.
Andreasen, N.C., Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatr. 39:7 (1982), 784–788, 10.1001/archpsyc.1982.04290070020005.
Arnould, A., Rochat, L., Azouvi, P.A., Multidimensional approach to apathy after 41 traumatic brain injury. Neuropsychol. Rev. 23 (2013), 210–233.
Artaloytia, Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry, 2006, 10.1176/appi.ajp.163.3.488.
Bates, Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med., 1993.
Bobes, J., Arango, C., Garcia-Garcia, M., Rejas, J., CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J. Clin. Psychiatr. 71:3 (2010), 280–286, 10.4088/JCP.08m04250yel.
Bortolon, C., Macgregor, A., Capdevielle, D., Raffard, S., Apathy in schizophrenia: a review of neuropsychological and neuroanatomical studies. Neuropsychologia 118 (2018), 22–33, 10.1016/j.neuropsychologia.2017.09.033.
Bowie, C.R., Twamley, E.W., Anderson, H., Halpern, B., Patterson, T.L., Harvey, P.D., Self-assessment of functional status in schizophrenia. J. Psychiatr. Res. 41:12 (2007), 1012–1018, 10.1016/j.jpsychires.2006.08.003.
in pressButcher, I., Berry, K., Haddock, G., Understanding individuals' subjective experiences of negative symptoms of schizophrenia: a qualitative study. Br. J. Clin. Psychol., 2020, 10.1111/bjc.12248.
Cooper, Assessing motivation orientations in schizophrenia: scale development and validation. Psychiatry Res, 2015, 10.1016/j.psychres.2014.10.013.
de Winter, J.C., Dodou, D., Wieringa, P.A., Exploratory factor Analysis with small sample sizes. Multivariate Behav. Res. 44 (2009), 147–181, 10.1080/00273170902794206.
Deci, The general causality orientations scale: self-determination in personality. J. Res. Pers, 2005.
Dollfus, Self-Evaluation of negative symptoms: a novel tool to assess negative symptoms. Schizophr Bull, 2016, 10.1093/schbul/sbv161.
Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J., The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatr. 33:6 (1976), 766–771, 10.1001/archpsyc.1976.01770060086012.
Engel, M., Lincoln, T.M., Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls. Psychiatr. Res. 247 (2017), 1–5, 10.1016/j.psychres.2016.11.013.
Fervaha, G., Takeuchi, H., Lee, J., Foussias, G., Fletcher, P.J., Agid, O., Remington, G., Antipsychotics and amotivation. Neuropsychopharmacology 40 (2015), 1539–1548, 10.1038/npp.2015.3.
Faerden, A., Lyngstad, S.H., Simonsen, C., Ringen, P.A., Papsuev, O., Dieset, I., Andreassen, O.A., Agartz, I., Marder, S.R., Melle, I., Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: concordance with the clinical version at baseline and 12 months follow-up. Psychiatr. Res. 267 (2018), 140–147, 10.1016/j.psychres.2018.05.065.
First, M., Spitzer, R., Gibbon, M., Williams, J., Structured Clinical Interview for DSM- IV Axis Disorders (SCID), Clinician Version: User's Guide. 1997. 1997, Am. Psychiatr. Press, Washington, DC.
Foussias, G., Remington, G., Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr. Bull. 36:2 (2010), 359–369, 10.1093/schbul/sbn094.
Fulford, D., Niendam, T.A., Floyd, E.G., Carter, C.S., Mathalon, D.H., Vinogradov, S., Stuart, B.K., Loewy, R.L., Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr. Res. 147 (2013), 125–131, 10.1016/j.schres.2013.03.024.
Galderisi, S., Mucci, A., Buchanan, R.W., Arango, C., Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatr. 5:8 (2018), 664–677, 10.1016/S2215-0366(18)30050-6.
Gilleen, J., Greenwood, K., David, A.S., Domains of awareness in schizophrenia. Schizophr. Bull. 37:1 (2011), 61–72, 10.1093/schbul/sbq100.
Goldring, A., Borne, S., Hefner, A., Thanju, A., Khan, A., Lindenmayer, J.P., The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS). Schizophr. Res. 224 (2020), 159–166, 10.1016/j.schres.2020.08.008.
Haggard, P., Human volition: towards a neuroscience of will. Nat. Rev. Neurosci. 9:12 (2008), 934–946, 10.1038/nrn2497.
Harvey, P.D., Raykov, T., Twamley, E.W., Vella, L., Heaton, R.K., Patterson, T.L., Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am. J. Psychiatr. 168:11 (2011), 1195–1201, 10.1176/appi.ajp.2011.10121723.
Kay, S.R., Fiszbein, A., Opler, L.A., The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:2 (1987), 261–276, 10.1093/schbul/13.2.261.
Kirkpatrick, B., Fenton, W.S., Carpenter, W.T. Jr., Marder, S.R., The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 32:2 (2006), 214–219, 10.1093/schbul/sbj053.
Kirkpatrick, B., Strauss, G.P., Nguyen, L., et al. The brief negative symptom scale: psychometric properties. Schizophr. Bull. 37:2 (2011), 300–305, 10.1093/schbul/sbq059.
Kirkpatrick, B., Developing concepts in negative symptoms: primary vs secondary and apathy vs expression. J. Clin. Psychiatr. 75:Suppl. 1 (2014), 3–7, 10.4088/JCP.13049su1c.01.
Kirschner, M., Aleman, A., Kaiser, S., Secondary negative symptoms - a review of mechanisms,assessment and treatment. Schizophr. Res. 186 (2017), 29–38, 10.1016/j.schres.2016.05.003.
Kring, A.M., Gur, R.E., Blanchard, J.J., Horan, W.P., Reise, S.P., The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am. J. Psychiatr. 170:2 (2013), 165–172, 10.1176/appi.ajp.2012.12010109.
Krynicki, et al. The relationship between negative symptoms and depression in schizophrenia: a systematic review. Acta Psychiatr Scand, 2018, 10.1111/acps.12873.
Le Heron, C., Apps, M.A.J., Husain, M., The anatomy of apathy: a neurocognitive framework for amotivated behaviour. Neuropsychologia 118 (2018), 54–67, 10.1016/j.neuropsychologia.2017.07.003.
Lincoln, T.M., Dollfus, S., Lyne, J., Current developments and challenges in the assessment of negative symptoms. Schizophr. Res. 186 (2017), 8–18, 10.1016/j.schres.2016.02.035.
Llerena, K., Park, S.G., McCarthy, J.M., Couture, S.M., Bennett, M.E., Blanchard, J.J. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr. Psychiatr.y 54(5), 568-574. doi: 10.1016/j.comppsych.2012.12.001.
Llerena, K., Reddy, L.F., Kern, R.S., The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia. Schizophr. Res. 192 (2018), 148–153, 10.1016/j.schres.2017.06.001.
Locke, E.A., Latham, G.P., Building a practically useful theory of goal setting and task motivation. A 35-year odyssey. Am. Psychol. 57:9 (2002), 705–717, 10.1037//0003-066x.57.9.705.
Luther, L., Fischer, M.W., Firmin, R.L., Salyers, M.P., Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: a meta-analysis. Schizophr. Res. 206 (2019), 27–36, 10.1016/j.schres.2018.10.010.
Marin, R.S., Biedrzycki, R.C., Firinciogullari, S., Reliability and validity of the apathy evaluation scale. Psychiatr. Res. 38:2 (1991), 143–162, 10.1016/0165-1781(91)90040-v.
Oddy, M., Cattran, C., Wood, R., The development of a measure of motivational changes following acquired brain injury. J. Clin. Exp. Neuropsychol. 30:5 (2008), 568–575, 10.1080/13803390701555598.
Patel, R., Jayatilleke, N., Broadbent, M., Chang, C.K., Foskett, N., Gorrell, G., Hayes, R.D., Jackson, R., Johnston, C., Shetty, H., Roberts, A., McGuire, P., Stewart, R., Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method. BMJ Open, 7(9), 2015, e007619, 10.1136/bmjopen-2015-007619 5.
Raffard, S., Gutierrez, L.A., Yazbek, H., Larue, A., Boulenger, J.P., Lançon, C., Benoit, M., Faget, C., Norton, J., Capdevielle, D., Working memory deficit as a risk factor for severe apathy in schizophrenia: a 1-year longitudinal study. Schizophr. Bull. 42:3 (2016), 642–651, 10.1093/schbul/sbw002.
Raffard, S., Rainteau, N., Bayard, S., Laraki, Y., Norton, J., Capdevielle, D., Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY). Trials, 17(1), 2020, 797, 10.1186/s13063-020-04606-6 21.
Richter, J., Hesse, K., Eberle, M.C., Eckstein, K.N., Zimmermann, L., Schreiber, L., Burmeister, C.P., Wildgruber, D., Klingberg, S., Self-assessment of negative symptoms - critical appraisal of the motivation and pleasure - self-report's (MAP-SR) validity and reliability. Compr. Psychiatr. 88 (2019), 22–28, 10.1016/j.comppsych.2018.10.007.
Ryan, R.M., Deci, E.L., Self-determination theory and the facilitation of intrinsic motivation, social development, and wellbeing. Am. Psychol. 55 (2000), 68–78.
Robert, P., Lanctôt, K.L., Agüera-Ortiz, L., Aalten, P., Bremond, F., Defrancesco, M., Hanon, C., David, R., Dubois, B., Dujardin, K., Husain, M., König, A., Levy, R., Mantua, V., Meulien, D., Miller, D., Moebius, H.J., Rasmussen, J., Robert, G., Ruthirakuhan, M., Stella, F., Yesavage, J., Zeghari, R., Manera, V., Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur. Psychiatr. 54 (2018), 71–76, 10.1016/j.eurpsy.2018.07.008.
Salamone, J.D., Yohn, S.E., López-Cruz, L., San Miguel, N., Correa, M., Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain 139 (2016), 1325–1347, 10.1093/brain/aww050.
Savill, M., Orfanos, S., Reininghaus, U., Wykes, T., Bentall, R., Priebe, S., The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia. Schizophr. Res. 176:2–3 (2016), 387–391, 10.1016/j.schres.2016.06.017 2016 Oct.
Schlosser, D.A., Fisher, M., Gard, D., Fulford, D., Loewy, R.L., Vinogradov S. Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia. Schizophr. Res. 158 (2014), 52–57, 10.1016/j.schres.2014.06.024.
Siddiqui, I., Saperia, S., Fervaha, G., Da Silva, S., Jeffay, E., Zakzanis, K.K., Agid, O., Remington, G., Foussias, G., Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environment. Schizophr. Res. 206 (2019), 400–406, 10.1016/j.schres.2018.10.012.
Sockeel, P., Dujardin, K., Devos, D., Denève, C., Destée, A., Defebvre, L., The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 77 (2006), 579–584.
Starkstein, S.E., Mayberg, H.S., Preziosi, T.J., Andrezejewski, P., Leiguarda, R., Robinson, R.G., Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J. Neuropsychiatry Clin. Neurosci. 4:2 (1992), 134–139, 10.1176/jnp.4.2.134.
Strauss, G.P., Cohen, A.S., A transdiagnostic review of negative symptom phenomenology and etiology. Schizophr. Bull. 43 (2017), 712–719, 10.1093/schbul/sbx066.
Strauss, G.P., Esfahlani, F.Z., Galderisi, S., Mucci, A., Rossi, A., Bucci, P., Rocca, P., Maj, M., Kirkpatrick, B., Ruiz, I., Sayama, H., Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr. Bull. 45:5 (2019), 1033–1041, 10.1093/schbul/sby133.
Strauss, G.P., Horan, W.P., Kirkpatrick, B., Fischer, B.A., Keller, W.R., Miski, P., Buchanan, R.W., Green, M.F., Carpenter, W.T. Jr., Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J. Psychiatr. Res. 47:6 (2013), 783–790, 10.1016/j.jpsychires.2013.01.015.
Strauss, G.P., Nuñez, A., Ahmed, A.O., Barchard, K.A., Granholm, E., Kirkpatrick, B., Gold, J.M., Allen, D.N., The latent structure of negative symptoms in schizophrenia. JAMA Psychiatr. 75:12 (2018), 1271–1279, 10.1001/jamapsychiatry.2018.2475.
Treadway, M.T., Buckholtz, J.W., Schwartzman, A.N., Lambert, W.E., Zald, D.H., Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One, 12(8), 2009, e6598, 10.1371/journal.pone.0006598 4.
Ventura, J., Hellemann, G.S., Thames, A.D., Koellner, V., Nuechterlein, K.H., Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr. Res. 113:2–3 (2009), 189–199, 10.1016/j.schres.2009.03.035.
Waters, F., Naik, N., Rock, D., Sleep, fatigue, and functional health in psychotic patients. Schizophr. Res. Treatment, 2013, 425826, 10.1155/2013/425826 2013.
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, V., Erikson, P., Principles of good practice for the translation and cultural adaptation process for patient reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8 (2005), 94–104.
Wieber, F., Thürmer, J.L., Gollwitzer, P.M., Promoting the translation of intentions into action by implementation intentions: behavioral effects and physiological correlates. Front. Hum. Neurosci., 14(9), 2015, 395, 10.3389/fnhum.2015.00395.
Yazbek, H., Norton, J., Capdevielle, D., Larue, A., Boulenger, J.P., Gély-Nargeot, M.C., Raffard, S., The Lille Apathy Rating Scale (LARS): exploring its psychometric properties in schizophrenia. Schizophr. Res. 157:1–3 (2013), 278–284, 10.1016/j.schres.2014.04.034.